Works matching IS 22965270 AND DT 2020 AND VI 43 AND IP 5
Results: 11
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 1, doi. 10.1159/000508384
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 246, doi. 10.1159/000508049
- Publication type:
- Article
Daratumumab erstmalig im Transplant-Setting zugelassen.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 245, doi. 10.1159/000508048
- Publication type:
- Article
Quality of Patient Information by Urologists Is Associated with Mental Distress in Bladder Cancer Patients.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 228, doi. 10.1159/000507094
- By:
- Publication type:
- Article
External Validation of a Prognostic Score for Patients with Brain Metastases: Extended Diagnosis-Specific Graded Prognostic Assessment.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 221, doi. 10.1159/000506954
- By:
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 254, doi. 10.1159/000506891
- Publication type:
- Article
Grading in Myxofibrosarcoma of the Extremities Can Predict Survival and Local Control.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 189, doi. 10.1159/000506844
- By:
- Publication type:
- Article
A Retrospective Analysis of Clinical Trial Accrual of Patients Presented in a Multidisciplinary Tumor Board at a Tertiary Health Care Center and Associated Barriers.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 196, doi. 10.1159/000506840
- By:
- Publication type:
- Article
Reproductive Risk Factors of Inflammatory Breast Cancer according to Luminal, HER2-Overexpressing, and Triple-Negative Subtypes: A Case Comparison Study.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 204, doi. 10.1159/000506691
- By:
- Publication type:
- Article
Metastatic Colorectal Carcinoma after Second Progression and the Role of Trifluridine-Tipiracil (TAS-102) in Switzerland.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 237, doi. 10.1159/000506080
- By:
- Publication type:
- Article
Impact of Immune Checkpoint Inhibitors with or without a Combination of Tyrosine Kinase Inhibitors on Organ-Specific Efficacy and Macrovascular Invasion in Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 5, p. 211, doi. 10.1159/000505933
- By:
- Publication type:
- Article